{"data":{"id":"us/21-cfr-358.301","jurisdiction":"us","citation":"21 CFR 358.301","heading":"Scope.","body":"(a) An over-the-counter ingrown toenail relief drug product in a form suitable for topical administration is generally recognized as safe and effective and is not misbranded if it meets each condition in this subpart and each general condition established in § 330.1 of this chapter.\n(b) References in this subpart to regulatory sections of the Code of Federal Regulations are to chapter 1 of title 21 unless otherwise noted.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 358—MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE","Subpart D—Ingrown Toenail Relief Drug Products"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"9921369238ddda528e621205406e9b2fc1f46d2288859c4b7d614ede842e7f14","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-358.150","next":"us/21-cfr-358.303"},"notice":"GroundRules: Original legal text. Not legal advice."}